The transfection method is utilized to introduce RNA, DNA, or protein products into cells, enabling modifications in the organism's phenotype and genotype. This process involves transferring new genes or gene constructs such as Clustered Regularly Interspaced Short Palindromic Repeats (CRISPR) for genome editing purposes. Transfection finds extensive applications in fields like immunotherapy, gene therapy, and cell therapy. It encompasses both non-viral and viral-mediated transfection, with non-viral methods achieved through chemical and physical approaches.
According to Data Bridge Market Research, the Transfection Reagent and Equipment Market is expected to reach USD 2,284,494.00 thousand by 2030. The market is expected to grow with a CAGR of 9.6% in the forecast period of 2023 to 2030.
“Development of synthetic biology products”
Synthetic biology represents a groundbreaking approach that applies engineering principles to biology. It encompasses the chemical synthesis of DNA and the reassembly of DNA genomes based on genomics knowledge. Genetic engineering, including transfection methods, plays a significant role in incorporating new genes into synthetic biology. With the growing global demand for synthetic biology products, there is a parallel increase in the utilization of transfection products.
What restraints the growth of the transfection reagent and equipment market?
“Cell damage induced by transfection procedure”
Certain transfection methods have been associated with cell damage, which can compromise the reproducibility of the overall procedure. Among various transfection techniques, electroporation has been identified as causing the most significant cell damage, particularly with increasing voltage. This cellular damage can adversely affect the efficiency and progress of ongoing projects utilizing transfection, highlighting the importance of carefully selecting transfection methods to minimize negative impacts.
Segmentation: Global Transfection Reagent and Equipment Market
The transfection reagent and equipment market is segmented on the basis of products, stage, methods, type, types of molecule, application, end user, organism, and distribution channel.
- On the basis of products, the transfection reagent and equipment market is segmented into instruments and reagent and kits.
- On the basis of stage, the transfection reagent and equipment market is segmented into research, preclinical, clinical phases and commercial.
- On the basis of methods, the transfection reagent and equipment market is segmented into non-viral methods and viral methods.
- On the basis of types, the transfection reagent and equipment market is segmented into transient transfection reagent and equipment and stable transfection reagent and equipment.
- On the basis of types of molecule, the transfection reagent and equipment market is segmented into plasmid DNA, DNA oligonucleotides, small interfering RNA (siRNA), proteins, ribonucleoprotein complexes (RNPs) and others.
- On the basis of application the transfection reagent and equipment market is segmented into in vitro application, in vivo application, bio production and others.
- On the basis of end user, the transfection reagent and equipment market is segmented into biopharma, CROs, CMOs/ CDMOs, academia, hospitals, clinical labs and others.
- On the basis of organism, the transfection reagent and equipment market is segmented into bacteria, mammalian cells, fungi, plants and virus.
- On the basis of distribution channel, the transfection reagent and equipment market is segmented into direct tender, retail sales, and others.
Regional Insights: North America dominates the Transfection Reagent and Equipment Market
North America dominates the market due to the presence of key market players in the largest consumer market with high GDP. U.S is expected to grow due to rise in the prevalence of chronic and rare diseases leading to increase in the use of transfection reagent and equipment. The increasing investment in healthcare is expected to boost the market growth. The U.S. dominates North America region due to strong presence of key players. Germany dominates Europe region due to the increasing demand from emerging markets and expansion. China dominates Asia-Pacific region due to due to increasing customer inclinations towards advanced technological processes.
To know more about the study visit, https://www.databridgemarketresearch.com/fr/reports/global-transfection-reagents-and-equipment-market
Recent Developments in Transfection Reagent and Equipment Market
- In August 2021, Mirus Bio expanded the TransIT VirusGen platform for Good Manufacturing Practice (GMP) viral vector production to support cell and gene therapy development, process operations, and commercial production. The extension, referred to as TransIT VirusGen GMP Transfection Reagent, is designed to improve the packaging and delivery of vector DNA to suspension and adherent HEK 293 cell types to improve the production of recombinant adeno-associated viruses and lentiviral vectors.
- In April 2021, BOC Sciences announced the launch of two in vivo RNA transfection kits, namely siRNA in vivo transfection kits and mRNA in vivo transfection kits, suitable for in vivo transfection of siRNA and mRNA, respectively.
The Prominent Key Players Operating in the Transfection Reagent and Equipment Market Include:
- Mirus Bio LLC (U.S.)
- Promega Corporation. (U.S.)
- Polyplus Transfection (France)
- Bio-Rad Laboratories, Inc. (U.S.)
- Merck KGaA (Germany)
- Lonza. (Switzerland)
- MaxCyte. (U.S.)
- Altogen Biosystems (U.S.)
- SBS Genetech (China)
- FUJIFILM Irvine Scientific (U.S.)
- Avanti Polar Lipids (U.S.)
- PerkinElmer chemagen Technologie GmbH (Germany)
- Cytiva (U.S.)
- Geno Technology Inc. (U.S.)
- USA, R&D Systems, Inc. (U.S.)
- akara Bio Inc. (Japan)
- Thermofisher Scientific Inc. (U.S.)
- Roche Molecular Systems, Inc. (U.S.)
- QIAGEN (Germany)
- OriGene Technologies, Inc. (U.S.)
Above are the key players covered in the report, to know about more and exhaustive list of transfection reagent and equipment market companies contact, https://www.databridgemarketresearch.com/fr/contact
Research Methodology: Global Transfection Reagent and Equipment Market
Data collection and base year analysis are done using data collection modules with large sample sizes. The market data is analyzed and estimated using market statistical and coherent models. In addition, market share analysis and key trend analysis are the major success factors in the market report. The key research methodology used by DBMR research team is data triangulation which involves data mining, analysis of the impact of data variables on the market, and primary (industry expert) validation. Apart from this, data models include Vendor Positioning Grid, Market Time Line Analysis, Market Overview and Guide, Company Positioning Grid, Company Market Share Analysis, Standards of Measurement, global vs Regional and Vendor Share Analysis. Please request analyst call in case of further inquiry.
